Literature DB >> 18988032

Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform.

Jenny A Cappuccio1, Angela K Hinz, Edward A Kuhn, Julia E Fletcher, Erin S Arroyo, Paul T Henderson, Craig D Blanchette, Vickie L Walsworth, Michele H Corzett, Richard J Law, Joseph B Pesavento, Brent W Segelke, Todd A Sulchek, Brett A Chromy, Federico Katzen, Todd Peterson, Graham Bench, Wieslaw Kudlicki, Paul D Hoeprich, Matthew A Coleman.   

Abstract

Membrane-associated proteins and protein complexes account for approximately a third or more of the proteins in the cell (1, 2). These complexes mediate essential cellular processes; including signal transduc-tion, transport, recognition, bioenergetics and cell-cell communication. In general, membrane proteins are challenging to study because of their insolubility and tendency to aggregate when removed from their protein lipid bilayer environment. This chapter is focused on describing a novel method for producing and solubilizing membrane proteins that can be easily adapted to high-throughput expression screening. This process is based on cell-free transcription and translation technology coupled with nanolipoprotein par ticles (NLPs), which are lipid bilayers confined within a ring of amphipathic protein of defined diameter. The NLPs act as a platform for inserting, solubilizing and characterizing functional membrane proteins. NLP component proteins (apolipoproteins), as well as membrane proteins can be produced by either traditional cell-based or as discussed here, cell-free expression methodologies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18988032     DOI: 10.1007/978-1-59745-196-3_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

Review 1.  Cell-free protein synthesis: applications come of age.

Authors:  Erik D Carlson; Rui Gan; C Eric Hodgman; Michael C Jewett
Journal:  Biotechnol Adv       Date:  2011-10-08       Impact factor: 14.227

Review 2.  Engineered nanoparticles mimicking cell membranes for toxin neutralization.

Authors:  Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Liangfang Zhang
Journal:  Adv Drug Deliv Rev       Date:  2015-04-11       Impact factor: 15.470

3.  Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.

Authors:  Li Zhou; Fei Li; Hai-Bing Xu; Chun-Xia Luo; Hai-Yin Wu; Ming-Mei Zhu; Wei Lu; Xing Ji; Qi-Gang Zhou; Dong-Ya Zhu
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

4.  A cell-free method for expressing and reconstituting membrane proteins enables functional characterization of the plant receptor-like protein kinase FERONIA.

Authors:  Benjamin B Minkoff; Shin-Ichi Makino; Miyoshi Haruta; Emily T Beebe; Russell L Wrobel; Brian G Fox; Michael R Sussman
Journal:  J Biol Chem       Date:  2017-02-24       Impact factor: 5.157

5.  Robotic large-scale application of wheat cell-free translation to structural studies including membrane proteins.

Authors:  Emily T Beebe; Shin-Ichi Makino; Akira Nozawa; Yuko Matsubara; Ronnie O Frederick; John G Primm; Michael A Goren; Brian G Fox
Journal:  N Biotechnol       Date:  2010-07-15       Impact factor: 5.079

6.  Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development.

Authors:  Wei He; Martina Felderman; Angela C Evans; Jia Geng; David Homan; Feliza Bourguet; Nicholas O Fischer; Yuanpei Li; Kit S Lam; Aleksandr Noy; Li Xing; R Holland Cheng; Amy Rasley; Craig D Blanchette; Kurt Kamrud; Nathaniel Wang; Heather Gouvis; Todd C Peterson; Bolyn Hubby; Matthew A Coleman
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

7.  The cell-free integration of a polytopic mitochondrial membrane protein into liposomes occurs cotranslationally and in a lipid-dependent manner.

Authors:  Ashley R Long; Catherine C O'Brien; Nathan N Alder
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

8.  Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen.

Authors:  Ingrid Babel; Rodrigo Barderas; Alberto Peláez-García; J Ignacio Casal
Journal:  BMC Biotechnol       Date:  2011-06-02       Impact factor: 2.563

9.  Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform.

Authors:  Nicholas O Fischer; Dina R Weilhammer; Alexis Dunkle; Cynthia Thomas; Mona Hwang; Michele Corzett; Cheri Lychak; Wasima Mayer; Salustra Urbin; Nicole Collette; Jiun Chiun Chang; Gabriela G Loots; Amy Rasley; Craig D Blanchette
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

10.  Fluorescent in situ folding control for rapid optimization of cell-free membrane protein synthesis.

Authors:  Annika Müller-Lucks; Sinja Bock; Binghua Wu; Eric Beitz
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.